Correlation Between Seres Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Seres Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Seres Therapeutics and Edgewise Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Seres and Edgewise is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 3.35 times more return on investment than Edgewise Therapeutics. However, Seres Therapeutics is 3.35 times more volatile than Edgewise Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 82.00 in Seres Therapeutics on September 1, 2024 and sell it today you would earn a total of 16.00 from holding Seres Therapeutics or generate 19.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Seres Therapeutics |
| Edgewise Therapeutics |
Seres Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Seres Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Lantern Pharma | Edgewise Therapeutics vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |